ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $108K of Arcutis Biotherapeutics, Inc.
Sold$107,695
$10.77Price
10,000Shares
−5%Stake
What ARQT did after the filing
- The stock from Fri, Sep 6 open, $10.82
- −19.4%
- S&P 500, same days
- +6.6%
Measured over 30 trading days, to the Oct 18 close.
Traded Tue, Sep 3. Filed Thu, Sep 5, 5:56 PM ET, after the close. Returns use the Sep 6 open and the Oct 18 close. Not investment advice.